Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Newly signed Texas law restricts abortion-inducing medications

Published 09/24/2021, 08:08 PM
Updated 09/24/2021, 08:36 PM
© Reuters. FILE PHOTO: Texas Governor Greg Abbott speaks at the annual National Rifle Association (NRA) convention in Dallas, Texas, U.S., May 4, 2018. REUTERS/Lucas Jackson

By Brad Brooks

LUBBOCK, Texas (Reuters) - Texas Governor Greg Abbott on Friday signed a new law that restricts access to abortion-inducing medications, just weeks after the state rolled out a near-total ban on abortion procedures.

The law on medications prohibits mail-order abortion-inducing drugs and says doctors in the state are only allowed to prescribe them up to seven weeks after conception. Previously that restriction was set at 10 weeks.

"Texas continues to lead the way in protecting unborn children and fostering a culture of life," Abbott said in a written statement. "We have taken monumental steps to save babies from the ravages of abortion."

Texas is at the center of the debate over abortion in the United States, enacting the most restrictive abortion laws in the country during recent legislative sessions.

On Sept. 1, a new Texas law went into effect that bans the procedure after a fetal heartbeat is detected - which is at about six weeks in most cases. Abortion rights groups say that 85% to 90% of all abortions are carried out after six weeks.

Texas is among a dozen mostly Republican-led states that have enacted "heartbeat" abortion bans that outlaw the procedure once the rhythmic contracting of fetal cardiac tissue can be detected - which is at times before a woman realizes she is pregnant. Courts have blocked such bans.

But the Texas law empowers private citizens anywhere to sue abortion providers and anybody who assists a woman in getting one. That helped shield the law from being immediately blocked as it made it more difficult to directly sue the government.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Abortion providers in Texas on Thursday asked the U.S. Supreme Court to intervene on an urgent basis in their challenge to a state law imposing a near-total ban on abortion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.